Skip to main content

Table 3 Multivariate analysis of independent prediction of silent liver fibrosis

From: Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate

 

Odds ratio

95% Confidentialinterval

P-value

Laboratory variables

   

Gamma-glutamyltranspeptidase, IU/L

1.009

0.953, 1.068

0.757

Cumulative dose of medications, mg

   

Leflunomide (53 patients)

1.000

1.000, 1.000

0.007

Prednisolone (89 patients)

1.000

1.000, 1.000

0.547